Compounds found in cannabis could provide a new roadmap for treating the world’s most common chronic liver disorder, ...

The FDA assigned a PDUFA target action date of December 22, 2026 –– The NDA is based on positive data from a successful clinical program ...

This press release is intended for US audiences for transparency relative to global news for the Fabry community. This dosing regimen for ...

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need ...

Honey is often praised for a range of health benefits, from soothing a sore throat and helping you get to sleep to healing woulds and lowering risk factors for diabetes and heart disease.

Read more about AI-powered peptide discovery could transform fight against drug-resistant superbugs on Devdiscourse ...

Cranberry juice is a better choice for reducing the risk of UTIs, while pomegranate juice may be more effective for lowering ...

FL, UNITED STATES, March 9, 2026 / EINPresswire.com / — Equator Pure Nature and Equator Management LLC today announced that their CEO, Peter Wainman, has been honored with the inaugural Grokipedia ...

Alexion, AstraZeneca Rare Disease's Koselugo (selumetinib), an oral, selective MEK inhibitor, has been approved in Canada for the treatment of adult patients with neurofibromatosis type 1 (NF1) who ...

To cut red tape and costs for importing and exporting with the EU, the UK will align with EU Sanitary and Phytosanitary (SPS) legislation. To cut red ...

Spruce Biosciences, Inc. , a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today ...

Data support potential of isaralgagene civaparvovec as a one-time, well tolerated and durable Fabry disease gene therapy to provide meaningful, multi-organ clinical benefits that could fundamentally ...